{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:15:07Z","timestamp":1775492107532,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"DOI":"10.7759\/cureus.70016","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:35:03Z","timestamp":1727112903000},"source":"Crossref","is-referenced-by-count":3,"title":["Association of Atypical Hemolytic Uremic Syndrome With Wilms' Tumor 1 Gene Mutations: A Case Series and Literature Review"],"prefix":"10.7759","author":[{"given":"Saeed","family":"Al Zabali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Alseneidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Faqeehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan","family":"Albatati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkarim","family":"Al Anazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0643-1","article-title":"Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report","volume":"18","author":"Alge JL","year":"2017","unstructured":"Alge JL, Wenderfer SE, Hicks J, Bekheirnia MR, Schady DA, Kain JS, Braun MC. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report. BMC Nephrol. 2017, 18:243. 10.1186\/s12882-017-0643-1","journal-title":"BMC Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01465-z","article-title":"Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry","volume":"36","author":"Halimi JM","year":"2023","unstructured":"Halimi JM, Al-Dakkak I, Anokhina K, et al.. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. J Nephrol. 2023, 36:817-28. 10.1007\/s40620-022-01465-z","journal-title":"J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2017.7053","article-title":"Atypical hemolytic uremic syndrome: a brief review","volume":"9","author":"Zhang K","year":"2017","unstructured":"Zhang K, Lu Y, Harley KT, Tran MH. Atypical hemolytic uremic syndrome: a brief review. Hematol Rep. 2017, 9:7053. 10.4081\/hr.2017.7053","journal-title":"Hematol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12763","article-title":"Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment","volume":"23","author":"Raina R","year":"2019","unstructured":"Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019, 23:4-21. 10.1111\/1744-9987.12763","journal-title":"Ther Apher Dial"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018833","article-title":"Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study","volume":"142","author":"Brocklebank V","year":"2023","unstructured":"Brocklebank V, Walsh PR, Smith-Jackson K, et al.. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. Blood. 2023, 142:1371-86. 10.1182\/blood.2022018833","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa062","article-title":"Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab","volume":"14","author":"Palma LM","year":"2021","unstructured":"Palma LM, Eick RG, Dantas GC, Tino MK, de Holanda MI. Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab. Clin Kidney J. 2021, 14:1126-35. 10.1093\/ckj\/sfaa062","journal-title":"Clin Kidney J"},{"key":"ref7","article-title":"Complete renal recovery following delayed therapy with eculizumab in atypical hemolytic uremic syndrome","volume":"1","author":"Alzabli SM","year":"2019","unstructured":"Alzabli SM, Al Anazi A, Ur Rahman MA, Rahim KA. Complete renal recovery following delayed therapy with eculizumab in atypical hemolytic uremic syndrome. Asian J Pediatr Nephrol. 2019, 1:33-7.","journal-title":"Asian J Pediatr Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2014.250","article-title":"Podocyte dysfunction in atypical haemolytic uraemic syndrome","volume":"11","author":"Noris M","year":"2015","unstructured":"Noris M, Mele C, Remuzzi G. Podocyte dysfunction in atypical haemolytic uraemic syndrome. Nat Rev Nephrol. 2015, 11:245-52.","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-024-06302-y","article-title":"WT1-related disorders: more than Denys-Drash syndrome","volume":"39","author":"Lopez-Gonzalez M","year":"2024","unstructured":"Lopez-Gonzalez M, Ariceta G. WT1-related disorders: more than Denys-Drash syndrome. Pediatr Nephrol. 2024, 39:2601-9. 10.1007\/s00467-024-06302-y","journal-title":"Pediatr Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.605889","article-title":"Case report: Denys-Drash syndrome with WT1 causative variant presenting as atypical hemolytic uremic syndrome","volume":"8","author":"Cheng C","year":"2020","unstructured":"Cheng C, Chen L, Wen S, Lin Z, Jiang X. Case report: Denys-Drash syndrome with WT1 causative variant presenting as atypical hemolytic uremic syndrome. Front Pediatr. 2020, 8:605889. 10.3389\/fped.2020.605889","journal-title":"Front Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90601-a","article-title":"Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms\u2019 tumor locus","volume":"60","author":"Call KM","year":"1990","unstructured":"Call KM, Glaser T, Ito CY, et al.. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms\u2019 tumor locus. Cell. 1990, 60:509-20. 10.1016\/0092-8674(90)90601-a","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.519","article-title":"Genotype-phenotype associations in WT1 glomerulopathy","volume":"85","author":"Lipska BS","year":"2014","unstructured":"Lipska BS, Ranchin B, Iatropoulos P, et al.. Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int. 2014, 85:1169-78. 10.1038\/ki.2013.519","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska A","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, et al.. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 2017, 91:937-47. 10.1016\/j.kint.2016.10.013","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000389","article-title":"Hemolytic uremic syndrome associated with Denys-Drash syndrome","volume":"14","author":"Sherbotie JR","year":"2000","unstructured":"Sherbotie JR, van Heyningen V, Axton R, Williamson K, Finn LS, Kaplan BS. Hemolytic uremic syndrome associated with Denys-Drash syndrome. Pediatr Nephrol. 2000, 14:1092-7. 10.1007\/s004670000389","journal-title":"Pediatr Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/346194a0","article-title":"The candidate Wilms' tumour gene is involved in genitourinary development","volume":"346","author":"Pritchard-Jones K","year":"1990","unstructured":"Pritchard-Jones K, Fleming S, Davidson D, et al.. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990, 346:194-7. 10.1038\/346194a0","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft220","article-title":"Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature","volume":"28","author":"Manenti L","year":"2013","unstructured":"Manenti L, Gnappi E, Vaglio A, et al.. Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant. 2013, 28:2246-59. 10.1093\/ndt\/gft220","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90194-4","article-title":"Germline mutations in the Wilms\u2019 tumor suppressor gene are associated with abnormal urogenital development in denys-drash syndrome","volume":"67","author":"Pelletier J","year":"1991","unstructured":"Pelletier J, Bruening W, Kashtan CE, et al.. Germline mutations in the Wilms\u2019 tumor suppressor gene are associated with abnormal urogenital development in denys-drash syndrome. Cell. 1991, 67:437-47. 10.1016\/0092-8674(91)90194-4","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(87)80199-5","article-title":"Complete and incomplete drash syndrome: a clinicopathologic study of five cases of a dysontogenetic-neoplastic complex","volume":"18","author":"Manivel JC","year":"1987","unstructured":"Manivel JC, Sibley RK, Dehner LP. Complete and incomplete drash syndrome: a clinicopathologic study of five cases of a dysontogenetic-neoplastic complex. Hum Pathol. 1987, 18:80-9. 10.1016\/S0046-8177(87)80199-5","journal-title":"Hum Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa474","article-title":"WT1 gene mutations in systemic lupus erythematosus with atypical haemolytic uremic syndrome","volume":"60","author":"Su CF","year":"2021","unstructured":"Su CF, Liao HT, Tsai CY. WT1 gene mutations in systemic lupus erythematosus with atypical haemolytic uremic syndrome. Rheumatology. 2021, 60:e81-2. 10.1093\/rheumatology\/keaa474","journal-title":"Rheumatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00597.2007","article-title":"New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes","volume":"295","author":"Morrison AA","year":"2008","unstructured":"Morrison AA, Viney RL, Saleem MA, Ladomery MR. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol. 2008, 295:F12-7. 10.1152\/ajprenal.00597.2007","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292106-association-of-atypical-hemolytic-uremic-syndrome-with-wilms-tumor-1-gene-mutations-a-case-series-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:35:06Z","timestamp":1727112906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292106-association-of-atypical-hemolytic-uremic-syndrome-with-wilms-tumor-1-gene-mutations-a-case-series-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.70016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}